Beyazit, FatmaUnsal, Mesut A.2025-01-272025-01-2720170932-0067https://doi.org/10.1007/s00404-017-4388-7https://hdl.handle.net/20.500.12428/12642[No abstract available]eninfo:eu-repo/semantics/closedAccessBiomarkers; Carcinoma, Ovarian Epithelial; Female; Humans; Interleukin-18; Ovarian Neoplasms; Prognosis; Receptors, Interleukin-18; interleukin 1 receptor; interleukin 18 receptor; interleukin 18 receptor alpha; interleukin 37; biological marker; interleukin 18; interleukin 18 receptor; cancer growth; carcinogenesis; female; human; inflammation; Letter; ovarian cancer cell line; ovary carcinoma; signal transduction; ovary tumor; prognosisIL18 receptors are required for IL-37-mediated epithelial ovarian tumor progressionLetter29561301130210.1007/s00404-017-4388-72-s2.0-8501834212728456842Q2